Abstract Objective To study the clinical characteristics and prognosis of SARS-CoV-2 Omicron variant infection-associated acute necrotizing encephalopathy (ANE) in children. Methods A retrospective analysis was conducted on the medical data of 12 children with SARS-CoV-2 Omicron variant infection-associated ANE who were admitted to the Pediatric Intensive Care Unit, Qingdao Women and Children′s Hospital from December 18 to 29, 2022. The children were divided into two groups based on outcomes: death group (7 cases) and survival group (5 cases). The clinical manifestations and auxiliary examination results were compared between the two groups. Results The median age of the 12 patients was 30 months, with a male-to-female ratio of 1:1. All patients presented with persistent high fever, with a median highest body temperature of 41℃. The median time from fever onset to seizure or consciousness disturbance was 18 hours. The death group had a higher proportion of neurogenic shock, coagulation dysfunction, as well as elevated lactate, D-dimer, interleukin-6, interleukin--8, and interleukin-10 levels compared to the survival group (P<0.05). Conclusions Children with SARS-CoV-2 Omicron variant infection-associated with ANE commonly present with persistent high fever, rapidly progressing disease, and have a high likelihood of developing consciousness disorders and multiorgan dysfunction within a short period. The occurrence of neurogenic shock, coagulation dysfunction, and significantly elevated cytokine levels suggests an increased risk of mortality.
Corresponding Authors:
Li J,E-mail：lisang1978@qq.com。
E-mail: lisang1978@qq.com
Cite this article:
SHEN Jin-Mei,LIU Rui-Hai,LI Zi-Pu et al. Clinical characteristics and prognosis in 12 children with SARS-CoV-2 Omicron variant infection-associated acute necrotizing encephalopathy[J]. CJCP, 2023, 25(11): 1170-1174.
SHEN Jin-Mei,LIU Rui-Hai,LI Zi-Pu et al. Clinical characteristics and prognosis in 12 children with SARS-CoV-2 Omicron variant infection-associated acute necrotizing encephalopathy[J]. CJCP, 2023, 25(11): 1170-1174.
Mizuguchi M, Ichiyama T, Imataka G, et al. Guidelines for the diagnosis and treatment of acute encephalopathy in childhood[J]. Brain Dev, 2021, 43(1): 2-31. PMID: . DOI: 10.1016/j.braindev.2020.08.001.
Okumura A, Abe S, Kidokoro H, et al. Acute necrotizing encephalopathy: a comparison between influenza and non-influenza cases[J]. Microbiol Immunol, 2009, 53(5): 277-280. PMID: 19457168. DOI: 10.1111/j.1348-0421.2009.00124.x.
Shukla P, Mandalla A, Elrick MJ, et al. Clinical manifestations and pathogenesis of acute necrotizing encephalopathy: the interface between systemic infection and neurologic injury[J]. Front Neurol, 2021, 12: 628811. PMID: 35058867. PMCID: PMC8764155. DOI: 10.3389/fneur.2021.628811.
Cloete J, Kruger A, Masha M, et al. Paediatric hospitalisations due to COVID-19 during the first SARS-CoV-2 Omicron (B.1.1.529) variant wave in South Africa: a multicentre observational study[J]. Lancet Child Adolesc Health, 2022, 6(5): 294-302. PMID: 35189083. PMCID: PMC8856663. DOI: 10.1016/S2352-4642(22)00027-X.
Lin JJ, Tu YF, Chen SJ, et al. Fatal fulminant cerebral edema in six children with SARS-CoV-2 Omicron BA.2 infection in Taiwan[J]. J Pediatric Infect Dis Soc, 2023, 12(2): 99-103. PMID: 36369959. DOI: 10.1093/jpids/piac116.
